Embotelladora Andina S.A. (AKO.A)

Akoya Biosciences Revenue

Embotelladora Andina had revenue of 738.15B CLP in the quarter ending June 30, 2025, with 9.81% growth. This brings the company's revenue in the last twelve months to 3.35T, up 21.71% year-over-year. In the year 2024, Embotelladora Andina had annual revenue of 3.22T with 23.14% growth.

• Revenue (ttm): 3,351.17B CLP
• Revenue Growth: +21.71%
• P/S Ratio: 0.93
• Revenue / Employee: 207,284,891 CLP
• Employees: 16,167
• Market Cap: 3.36B USD

Revenue Chart

* This company reports financials in CLP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3,224.23B	605.80B	23.14%
Dec 31, 2023	2,618.44B	-38.44B	-1.45%
Dec 31, 2022	2,656.88B	440.15B	19.86%
Dec 31, 2021	2,216.73B	518.45B	30.53%
Dec 31, 2020	1,698.28B	-80.74B	-4.54%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.